Skip to main content

Research Repository

Advanced Search

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials

McGarvey, Lorcan; Morice, Alyn H.; Smith, Jaclyn A.; Birring, Surinder S.; Chuecos, Ferran; Seoane, Beatriz; Jarreta, Diana

Authors

Lorcan McGarvey

Jaclyn A. Smith

Surinder S. Birring

Ferran Chuecos

Beatriz Seoane

Diana Jarreta



Abstract

© 2016, BMJ Publishing Group. All rights reserved. Background: Cough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of aclidinium bromide 400 μg twice daily in patients with stable COPD has been established in two phase III studies (ACCORD COPD I and ATTAIN) and a phase IIIb active-comparator study. This analysis evaluated cough-related symptoms across these studies. Method: Patients were randomised to placebo, aclidinium 200 μg or 400 μg twice daily in ACCORD (12 weeks) and ATTAIN (24 weeks), or to placebo, aclidinium 400 μg twice daily or tiotropium 18 μg once daily (6-week active-comparator study). Analysed end points included changes from baseline in Evaluating Respiratory Symptoms (E-RS; formerly known as EXAcerbations of Chronic pulmonary disease Tool), total and cough/sputum scores and frequency/severity of morning and night-time cough and sputum symptoms. Results: Data for 1792 patients were evaluated. E-RS cough/sputum domain scores were significantly reduced with aclidinium 400 μg versus placebo in ATTAIN (−0.7 vs −0.3, respectively; p

Citation

McGarvey, L., Morice, A. H., Smith, J. A., Birring, S. S., Chuecos, F., Seoane, B., & Jarreta, D. (2016). Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respiratory Research, 3(1), Article e000148. https://doi.org/10.1136/bmjresp-2016-000148

Journal Article Type Article
Acceptance Date Oct 24, 2016
Online Publication Date Dec 8, 2016
Publication Date 2016
Deposit Date May 12, 2022
Publicly Available Date May 16, 2022
Journal BMJ Open Respiratory Research
Electronic ISSN 2052-4439
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 3
Issue 1
Article Number e000148
DOI https://doi.org/10.1136/bmjresp-2016-000148
Public URL https://hull-repository.worktribe.com/output/3609892

Files







You might also like



Downloadable Citations